Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free irwd Stock Alerts $8.12 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateMay. 9ConfirmedConsensus EPS (May. 9) $0.19 Listen to Call Get Ironwood Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for IRWD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIRWD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IRWD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Ironwood Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.14$0.18$0.16 Q2 20242$0.17$0.21$0.19 Q3 20242$0.12$0.18$0.15 Q4 20242$0.10$0.18$0.14 FY 20248$0.53$0.75$0.64 Q1 20251$0.21$0.21$0.21 Q2 20251$0.22$0.22$0.22 Q3 20251$0.21$0.21$0.21 Q4 20251$0.21$0.21$0.21 FY 20254$0.85$0.85 $0.85IRWD Earnings Date and InformationIronwood Pharmaceuticals last issued its quarterly earnings data on May 9th, 2024. The biotechnology company reported $0.00 EPS for the quarter, missing analysts' consensus estimates of $0.19 by $0.19. Ironwood Pharmaceuticals has generated ($6.51) earnings per share over the last year (($6.51) diluted earnings per share). Earnings for Ironwood Pharmaceuticals are expected to grow by 21.13% in the coming year, from $0.71 to $0.86 per share. Ironwood Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Ironwood Pharmaceuticals will be holding an earnings conference call on Thursday, May 9th at 8:30 AM Eastern. Interested parties can register for or listen to the call. or dial in at 609-800-9909 with passcode "3416473". Read More Ironwood Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)-$0.19----- 11/9/2023Q3 2023$0.17$0.12($0.05)$0.15$112.90 million$113.74 million 8/8/2023Q2 2023$0.25$0.31+$0.06$7.46$103.46 million$107.38 million5/4/2023Q1 2023$0.24$0.25+$0.01$0.25$100.60 million$104.06 million 2/16/2023Q4 2022$0.28$0.27($0.01)$0.27$108.23 million$107.20 million 11/3/2022Q3 2022$0.27$0.28+$0.01$0.28$111.51 million$108.64 million8/4/2022Q2 2022$0.31$0.21($0.10)$0.21$103.51 million$97.23 million Get the Latest News and Ratings for IRWD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/5/2022Q1 2022$0.27$0.21($0.06)$0.21$96.62 million$97.53 million 2/17/2022Q4 2021$0.31$0.27($0.04)$0.29$110.18 million$117.13 million 11/4/2021Q3 2021$0.31$0.33+$0.02$0.32$105.27 million$103.75 million 8/5/2021Q2 2021$0.23$0.34+$0.11($1.71)$92.47 million$104.00 million Ironwood Pharmaceuticals Earnings - Frequently Asked Questions When is Ironwood Pharmaceuticals's earnings date? Ironwood Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on IRWD's earnings history. Did Ironwood Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Ironwood Pharmaceuticals (NASDAQ:IRWD) missed the analysts' consensus estimate of $0.19 by $0.19 with a reported earnings per share (EPS) of $0.00. Learn more on analysts' earnings estimate vs. IRWD's actual earnings. How can I listen to Ironwood Pharmaceuticals's earnings conference call? The conference call for Ironwood Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How much revenue does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $442.73 million. How much profit does Ironwood Pharmaceuticals generate each year? Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of -$1.00 billion. IRWD has generated -$6.51 earnings per share over the last four quarters. What is Ironwood Pharmaceuticals's EPS forecast for next year? Ironwood Pharmaceuticals's earnings are expected to grow from $0.71 per share to $0.86 per share in the next year, which is a 21.13% increase. More Earnings Resources from MarketBeat Related Companies: Ligand Pharmaceuticals Earnings Date MannKind Earnings Date Dynavax Technologies Earnings Date OPKO Health Earnings Date Cryoport Earnings Date Zentalis Pharmaceuticals Earnings Date IGM Biosciences Earnings Date Lexicon Pharmaceuticals Earnings Date Geron Earnings Date Amicus Therapeutics Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:IRWD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
